Skip to main content
Fig. 4 | Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Fig. 4

From: Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)

Fig. 4

The area under the curve for mortality in patients acutely admitted. Comparison of prognostic ability of four biomarkers and age at 2 days, 30 days, 60 days, 90 days, and at the end of follow-up. suPAR vs. CRP, all time points: P < 0.001. suPAR vs. haemoglobin, all time points: P < 0.001. SuPAR vs albumin: 2 days: P = 0.37, suPAR vs. albumin at other time points: P < 0.001. CRP: C-reactive protein, suPAR: soluble urokinase plasminogen activator receptor

Back to article page

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

ISSN: 1757-7241